Pharma
The science behind the therapy that catapulted a biopharma’s stock 1,400% and counting
Spruce Biosciences saw its stock soar after months of decline, thanks to a new drug for a rare disease.
Rare Disease Research
How rare disease research is shaping the future of healthcare, featuring expert insights, data-driven stories, and the latest industry developments.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
